The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
The major inflammatory mediator interleukin-6 and obesity
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Increased oxidative stress in obesity and its impact on metabolic syndrome
Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., & Shimomura, I. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21625 · Cited by 5,508 · cited 2×
“[45] have demonstrated that in nondiabetic human subjects, fat accumulation closely correlates with the markers of systemic oxidative stress.”
BackgroundInflammation and insulin resistance
Shoelson, S. E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29069 · Cited by 4,769
Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes
Özcan, U., Cao, Q., Yilmaz, E., Lee, A.-H., Iwakoshi, N. N., Özdelen, E., Tuncman, G., Görgün, C., Glimcher, L. H., & Hotamisligil, G. S. (2004) · Science · doi:10.1126/science.1103160 · Cited by 3,844
The anti-inflammatory effect of exercise
Petersen, A. M. W., & Pedersen, B. K. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00164.2004 · Cited by 3,100 · cited 1×
“IL-6 is released from skeletal muscle during exercise and is related to exercise intensity [66].”
BackgroundAdipose tissue, adipokines, and inflammation
Fantuzzi, G. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.02.023 · Cited by 2,606 · cited 1×
“Adiponectin, the anti-inflammatory adipokine, can inhibit IL-6 production accompanied by induction of the antiinflammatory cytokines IL-10 and IL-1 receptor antagonist [55].”
BackgroundYudkin, J. S., Stehouwer, C. D. A., Emeis, J. J., & Coppack, S. W. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.4.972 · Cited by 2,465
Adipokines: inflammation and the pleiotropic role of white adipose tissue
Trayhurn, P., & Wood, I. S. (2004) · British Journal of Nutrition · doi:10.1079/bjn20041213 · Cited by 2,210
Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-α,in Vivo1
Mohamed-Ali, V., Goodrick, S., Rawesh, A., Katz, D. R., Miles, J. M., Yudkin, J. S., Klein, S., & Coppack, S. W. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4450 · Cited by 2,012
Esposito, K., Nappo, F., Marfella, R., Giugliano, G., Giugliano, F., Ciotola, M., Quagliaro, L., Ceriello, A., & Giugliano, D. (2002) · Circulation · doi:10.1161/01.cir.0000034509.14906.ae · Cited by 1,961 · cited 1×
“In patients with impaired glucose tolerance, the IL-6 level was higher than in the healthy (but insulin secretion blocked) controls and the increased plasma level lasted longer [63].”
BackgroundGender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production
Naugler, W. E., Sakurai, T., Kim, S., Maeda, S., Kim, K., Elsharkawy, A. M., & Karin, M. (2007) · Science · doi:10.1126/science.1140485 · Cited by 1,955
Kern, P. A., Ranganathan, S., Li, C., Wood, L., & Ranganathan, G. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.5.e745 · Cited by 1,883 · cited 2×
“Accordingly, circulating IL-6 levels are two- to threefold higher in obese type 2 diabetics than in nonobese controls [29, 38].”
BackgroundInoguchi, T., Li, P., Umeda, F., Yu, H. Y., Kakimoto, M., Imamura, M., Aoki, T., Etoh, T., Hashimoto, T., Naruse, M., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1939 · Cited by 1,577
Fain, J. N., Madan, A. K., Hiler, M. L., Cheema, P., & Bahouth, S. W. (2004) · Endocrinology · doi:10.1210/en.2003-1336 · Cited by 1,572
Fried, S. K., Bunkin, D. A., & Greenberg, A. S. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.3.4660 · Cited by 1,528
Xing, Z., Gauldie, J., Cox, G., Baumann, H., Jordana, M., Lei, X. F., & Achong, M. K. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1368 · Cited by 1,498
Inflammatory Cytokines and the Risk to Develop Type 2 Diabetes
Spranger, J., Kroke, A., Möhlig, M., Hoffmann, K., Bergmann, M. M., Ristow, M., Boeing, H., & Pfeiffer, A. F. H. (2003) · Diabetes · doi:10.2337/diabetes.52.3.812 · Cited by 1,493
Interleukin-6 in Biology and Medicine
Akira, S., Taga, T., & Kishimoto, T. (1993) · Advances in Immunology · doi:10.1016/s0065-2776(08)60532-5 · Cited by 1,389
HIF-1 and mechanisms of hypoxia sensing
Semenza, G. L. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00194-0 · Cited by 1,268
Pathophysiology of insulin resistance in human disease
Reaven, G. M. (1995) · Physiological Reviews · doi:10.1152/physrev.1995.75.3.473 · Cited by 1,226
Interleukin-6-deficient mice develop mature-onset obesity
Wallenius, V., Wallenius, K., Ahrén, B., Rudling, M., Carlsten, H., Dickson, S. L., Ohlsson, C., & Jansson, J.-O. (2002) · Nature Medicine · doi:10.1038/nm0102-75 · Cited by 1,213
Fried, S. K. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.3.847 · Cited by 1,145
Bastard, J.-P. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.9.3338 · Cited by 1,104
Lipotoxicity in the Pathogenesis of Obesity-Dependent NIDDM: Genetic and Clinical Implications
Unger, R. H. (1995) · Diabetes · doi:10.2337/diab.44.8.863 · Cited by 1,100
Rotter, V., Nagaev, I., & Smith, U. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301977200 · Cited by 1,062
Festa, A., D’Agostino, R., Tracy, R. P., & Haffner, S. M. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1131 · Cited by 1,057
Aguirre, V., Werner, E. D., Giraud, J., Lee, Y. H., Shoelson, S. E., & White, M. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m101521200 · Cited by 1,010 · cited 1×
“One possible mechanism is the serine phosphorylation of insulin receptor substrate 1 (IRS-1) by cytokine-activated kinases and the subsequent direct inhibitory effect on the insulin-signaling cascade [98].”
BackgroundAdipose tissue as an endocrine and paracrine organ
Mohamed-Ali, V, Pinkney, J., & Coppack, S. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800770 · Cited by 999
Vgontzas, A. N., Papanicolaou, D. A., Bixler, E. O., Kales, A., Tyson, K., & Chrousos, G. P. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.5.3950 · Cited by 974
Adipokines: molecular links between obesity and atheroslcerosis
Lau, D. C. W., Dhillon, B., Yan, H., Szmitko, P. E., & Verma, S. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01058.2004 · Cited by 931
Pou, K. M., Massaro, J. M., Hoffmann, U., Vasan, R. S., Maurovich-Horvat, P., Larson, M. G., Keaney, J. F., Meigs, J. B., Lipinska, I., Kathiresan, S., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.710509 · Cited by 896
Interleukin-6 induces cellular insulin resistance in hepatocytes.
Senn, J. J., Klover, P. J., Nowak, I. A., & Mooney, R. A. (2002) · Diabetes · doi:10.2337/diabetes.51.12.3391 · Cited by 883 · cited 2×
“Furthermore, acute and chronic in vivo IL-6 exposure inhibited hepatic insulin sensitivity [94].”
BackgroundGenovese, M. C., McKay, J. D., Nasonov, E. L., Mysler, E. F., da Silva, N. A., Alecock, E., Woodworth, T., & Gomez‐Reino, J. J. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23940 · Cited by 855 · cited 1×
“Plasma lipid levels (total cholesterol, LDL) also increased upon treatment with tocilizumab (at a dose of 8 mg/kg) in an other study (TOWARD, Tocilizumab in combination with traditional DMARD therapy) where patients suffering from rheumatoid arthritis were treated with humanized anti-IL-6 receptor monoclonal antibody…”
BackgroundIs obesity an inflammatory condition?
Das, U. N. (2001) · Nutrition · doi:10.1016/s0899-9007(01)00672-4 · Cited by 799
Nishimoto, N., Yoshizaki, K., Miyasaka, N., Yamamoto, K., Kawai, S., Takeuchi, T., Hashimoto, J., Azuma, J., & Kishimoto, T. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20303 · Cited by 788
Bruun, J. M., Lihn, A. S., Verdich, C., Pedersen, S. B., Toubro, S., Astrup, A., & Richelsen, B. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00110.2003 · Cited by 775
Interleukin-6 stimulates lipolysis and fat oxidation in humans
van Hall, G., Steensberg, A., Sacchetti, M., Fischer, C., Keller, C., Schjerling, P., Hiscock, N., Møller, K., Saltin, B., Febbraio, M. A., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021687 · Cited by 767
Humanized anti–interleukin-6 receptor antibody treatment of multicentric Castleman disease
Nishimoto, N., Kanakura, Y., Aozasa, K., Johkoh, T., Nakamura, M., Nakano, S., Nakano, N., Ikeda, Y., Sasaki, T., Nishioka, K., et al. (2005) · Blood · doi:10.1182/blood-2004-12-4602 · Cited by 754
Circulating Interleukin‐6 in Relation to Adiposity, Insulin Action, and Insulin Secretion
Vozarova, B., Weyer, C., Hanson, K., Tataranni, P. A., Bogardus, C., & Pratley, R. E. (2001) · Obesity Research · doi:10.1038/oby.2001.54 · Cited by 639
IL-6 and APPs: anti-inflammatory and immunosuppressive mediators
Tilg, H., Dinarello, C. A., & Mier, J. W. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)01103-1 · Cited by 633
Senn, J. J., Klover, P. J., Nowak, I. A., Zimmers, T. A., Koniaris, L. G., Furlanetto, R. W., & Mooney, R. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210689200 · Cited by 620
A Stress Signaling Pathway in Adipose Tissue Regulates Hepatic Insulin Resistance
Sabio, G., Das, M., Mora, A., Zhang, Z., Jun, J. Y., Ko, H. J., Barrett, T., Kim, J. K., & Davis, R. J. (2008) · Science · doi:10.1126/science.1160794 · Cited by 604
Signalling role of adipose tissue: adipokines and inflammation in obesity
Trayhurn, P., & Wood, I. S. (2005) · Biochemical Society Transactions · doi:10.1042/bst0331078 · Cited by 588
Regulation of adipocytokines and insulin resistance
Fasshauer, M., & Paschke, R. (2003) · Diabetologia · doi:10.1007/s00125-003-1228-z · Cited by 545
Interleukin-6 in human multiple myeloma
Klein, B., Zhang, X., Lu, Z., & Bataille, R. (1995) · Blood · doi:10.1182/blood.v85.4.863.bloodjournal854863 · Cited by 520
Trikha, M., Corringham, R. E., Klein, B., & Rossi, J. (2003) · PubMed · Cited by 506
The Hyperglycemia-induced Inflammatory Response in Adipocytes
Lin, Y., Berg, A. H., Iyengar, P., Lam, T. K. T., Giacca, A., Combs, T. P., Rajala, M. W., Du, X., Rollman, B., Li, W., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411863200 · Cited by 497
Chronic Exposure to Interleukin-6 Causes Hepatic Insulin Resistance in Mice
Klover, P. J., Zimmers, T. A., Koniaris, L. G., & Mooney, R. A. (2003) · Diabetes · doi:10.2337/diabetes.52.11.2784 · Cited by 488 · cited 1×
“Experiments have demonstrated that IL-6 can reduce insulin-dependent hepatic glycogen synthesis [93, 94] and glucose uptake in adipocytes [95].”
BackgroundSOCS-3 Is an Insulin-induced Negative Regulator of Insulin Signaling
Emanuelli, B., Peraldi, P., Filloux, C., Sawka-Verhelle, D., Hilton, D., & Van Obberghen, E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.21.15985 · Cited by 468
Nicklas, B. J., Ambrosius, W., Messier, S. P., Miller, G. D., Penninx, B. W., Loeser, R. F., Palla, S., Bleecker, E., & Pahor, M. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.4.544 · Cited by 443
Transcription Factor NF‐κB: A Sensor for Smoke and Stress Signals
AHN, K. S., & AGGARWAL, B. B. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1352.026 · Cited by 432
Kopp, H. P., Kopp, C. W., Festa, A., Krzyzanowska, K., Kriwanek, S., Minar, E., Roka, R., & Schernthaner, G. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000073313.16135.21 · Cited by 427 · cited 1×
“[71] and Vazquez et al.”
Cancello, R., & Clément, K. (2006) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2006.01004.x · Cited by 418
Wang, B., Wood, I. S., & Trayhurn, P. (2007) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-007-0301-8 · Cited by 392
Martin, C., Boisson, C., Haccoun, M., Thomachot, L., & Mege, J.-L. (1997) · Critical Care Medicine · doi:10.1097/00003246-199711000-00018 · Cited by 356
Raised Interleukin‐6 Levels in Obese Patients
Roytblat, L., Rachinsky, M., Fisher, A., Greemberg, L., Shapira, Y., Douvdevani, A., & Gelman, S. (2000) · Obesity Research · doi:10.1038/oby.2000.86 · Cited by 346
Somers, W. (1997) · The EMBO Journal · doi:10.1093/emboj/16.5.989 · Cited by 335
Dose-Dependent Effects of Recombinant Human Interleukin-6 on Glucose Regulation
Tsigos, C., Papanicolaou, D. A., Kyrou, I., Defensor, R., Mitsiadis, C. S., & Chrousos, G. P. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4422 · Cited by 324 · cited 1×
“(as determined by impaired insulin receptor signal transduction) in both rodents and humans [97].”
BackgroundPetersen, E. W., Carey, A. L., Sacchetti, M., Steinberg, G. R., Macaulay, S. L., Febbraio, M. A., & Pedersen, B. K. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00257.2004 · Cited by 311
Onset of obesity in a 36 year birth cohort study.
Braddon, F. E., Rodgers, B., Wadsworth, M. E., & Davies, J. M. (1986) · BMJ · doi:10.1136/bmj.293.6542.299 · Cited by 302
Aging Up-Regulates Expression of Inflammatory Mediators in Mouse Adipose Tissue
Wu, D., Ren, Z., Pae, M., Guo, W., Cui, X., Merrill, A. H., & Meydani, S. N. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.7.4829 · Cited by 287
Black, P. H. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.04.008 · Cited by 276
Interleukin-6 is a potent myeloma-cell growth factor in patients with aggressive multiple myeloma
Zhang, X., Klein, B., & Bataille, R. (1989) · Blood · doi:10.1182/blood.v74.1.11.11 · Cited by 266
Chung, S., LaPoint, K., Martinez, K., Kennedy, A., Boysen Sandberg, M., & McIntosh, M. K. (2006) · Endocrinology · doi:10.1210/en.2006-0536 · Cited by 252
May, L. T., Ghrayeb, J., Santhanam, U., Tatter, S. B., Sthoeger, Z., Helfgott, D. C., Chiorazzi, N., Grieninger, G., & Sehgal, P. B. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68564-3 · Cited by 250
Interleukin-6 Regulates Human Adipose Tissue Lipid Metabolism and Leptin Production in Vitro
Trujillo, M. E., Sullivan, S., Harten, I., Schneider, S. H., Greenberg, A. S., & Fried, S. K. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0603 · Cited by 248
Sopasakis, V. R., Sandqvist, M., Gustafson, B., Hammarstedt, A., Schmelz, M., Yang, X., Jansson, P., & Smith, U. (2004) · Obesity Research · doi:10.1038/oby.2004.51 · Cited by 243
Effects of recombinant human interleukin-6 in cancer patients: a phase I-II study
van Gameren, M., Willemse, P., Mulder, N., Limburg, P., Groen, H., Vellenga, E., & de Vries, E. (1994) · Blood · doi:10.1182/blood.v84.5.1434.1434 · Cited by 214
Vázquez, L. A., Pazos, F., Berrazueta, J. R., Fernández-Escalante, C., García-Unzueta, M. T., Freijanes, J., & Amado, J. A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032059 · Cited by 205
Oberbach, A., Tönjes, A., Klöting, N., Fasshauer, M., Kratzsch, J., Busse, M. W., Paschke, R., Stumvoll, M., & Blüher, M. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02127 · Cited by 199
Innate Immunity Modulates Adipokines in Humans
Anderson, P. D., Mehta, N. N., Wolfe, M. L., Hinkle, C. C., Pruscino, L., Comiskey, L. L., Tabita-Martinez, J., Sellers, K. F., Rickels, M. R., Ahima, R. S., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2545 · Cited by 198
Laimer, M., Ebenbichler, C., Kaser, S., Sandhofer, A., Weiss, H., Nehoda, H., Aigner, F., & Patsch, Jr. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0801970 · Cited by 191
Anorexia of infection: current prospects
Langhans, W. (2000) · Nutrition · doi:10.1016/s0899-9007(00)00421-4 · Cited by 183
Krogh‐Madsen, R., Plomgaard, P., Keller, P., Keller, C., & Pedersen, B. K. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00274.2003 · Cited by 174
Peters, M., Schirmacher, P., Goldschmitt, J., Odenthal, M., Peschel, C., Fattori, E., Ciliberto, G., Dienes, H.-P., Büschenfelde, K.-H. M. Z., & Rose-John, S. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.4.755 · Cited by 170
Metabolic Actions of Adipocyte Hormones: Focus on Adiponectin
Ahima, R. S. (2006) · Obesity · doi:10.1038/oby.2006.276 · Cited by 162
Di Gregorio, G. B., Hensley, L., Lu, T., Ranganathan, G., & Kern, P. A. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00189.2003 · Cited by 161
Interleukin‐6 production in human subcutaneous abdominal adipose tissue: the effect of exercise
Lyngsø, D., Simonsen, L., & Bülow, J. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2002.019380 · Cited by 155
Longitudinal changes in pancreatic and adipocyte hormones following Roux-en-Y gastric bypass surgery
Swarbrick, M. M., Stanhope, K. L., Austrheim-Smith, I. T., Loan, M. D. V., Ali, M. R., Wolfe, B. M., & Havel, P. J. (2008) · Diabetologia · doi:10.1007/s00125-008-1118-5 · Cited by 136
Chan, J., Cheung, J., Stehouwer, C. D. A., Emeis, J. J., Tong, P. C. Y., Ko, G., & Yudkin, J. S. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802017 · Cited by 135
Hormonal regulation of interleukin-6 production in human adipocytes
Vicennati, V., Vottero, A., Friedman, C., & Papanicolaou, D. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802035 · Cited by 134
Insulin Action in the Vasculature: Physiology and Pathophysiology
Mather, K. J., Anderson, T. J., & Verma, S. (2001) · Journal of Vascular Research · doi:10.1159/000051074 · Cited by 123
Émilie, D., Wijdenes, J., Gisselbrecht, C., Jarrousse, B., Billaud, É., Blay, J., Gabarre, J., Gaillard, J., Brochier, J., & Raphaël, M. (1994) · Blood · doi:10.1182/blood.v84.8.2472.2472 · Cited by 122
Leptin-Dependent Toll-Like Receptor Expression and Responsiveness in Preadipocytes and Adipocytes
Batra, A., Pietsch, J., Fedke, I., Glauben, R., Okur, B., Stroh, T., Zeitz, M., & Siegmund, B. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060699 · Cited by 118
The Obesity Epidemic in the United States
Morrill, A. C., & Chinn, C. D. (2004) · Journal of Public Health Policy · doi:10.1057/palgrave.jphp.3190035 · Cited by 117
Prognostic value of serum interleukin-6 in diffuse large-cell lymphoma
Preti, H. A., Cabanillas, F., Talpaz, M., Tucker, S. L., Seymour, J. F., & Kurzrock, R. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-3-199708010-00002 · Cited by 112
Impact of Gender and Menstrual Cycle Phase on Plasma Cytokine Concentrations
O’Brien, S. M., Fitzgerald, P., Scully, P., Landers, A., Scott, L. V., & Dinan, T. G. (2007) · NeuroImmunoModulation · doi:10.1159/000107423 · Cited by 110
Simons, P. J., van den Pangaart, P. S., Aerts, J. M. F. G., & Boon, L. (2007) · Journal of Endocrinology · doi:10.1677/joe-06-0047 · Cited by 104
Weigert, J., Neumeier, M., Schäffler, A., Fleck, M., Schölmerich, J., Schütz, C., & Buechler, C. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.09.022 · Cited by 93
Fulop, A. K., Földes, A., Buzás, E. I., Hegyi, K., Miklós, I., Romics, L., Kleiber, M., Nagy, A., Falus, A., & Kovács, K. (2003) · Endocrinology · doi:10.1210/en.2003-0222 · Cited by 87
Self-citationLin, E., Phillips, L. S., Ziegler, T. R., Schmotzer, B. J., Wu, K., Gu, L. H., Khaitan, L., Lynch, S. A., Torres, W. E., Smith, C. D., et al. (2007) · Diabetes · doi:10.2337/db06-1161 · Cited by 80
Transcriptomics applied to obesity and caloric restriction
Viguerie, N., Poitou, C., Cancello, R., Stich, V., Clément, K., & Langin, D. (2005) · Biochimie · doi:10.1016/j.biochi.2004.12.011 · Cited by 74 · cited 1×
“In the last decade, several studies have shown elevated IL-6 levels in obese patients [11]; however, data regarding the relevance of IL-6 are controversial [10–18].”
BackgroundPhosphorylation of secreted forms of human β2-interferon/hepatocyte stimulating factor/interleukin-6
May, L. T., Santhanam, U., Tatter, S. B., Bhardwaj, N., Ghrayeb, J., & Sehgal, P. B. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)80404-2 · Cited by 73
Cytokines and sickness behavior: implications from knockout animal models
Inui, A. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)01981-0 · Cited by 61
CANCER CACHEXIA IS MEDIATED IN PART BY THE INDUCTION OF IL-6-LIKE CYTOKINES FROM THE SPLEEN
Barton, B. E., & Murphy, T. F. (2001) · Cytokine · doi:10.1006/cyto.2001.0968 · Cited by 58
Giraldo, E., Hinchado, M. D., García, J. J., & Ortega, E. (2008) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-008-9752-2 · Cited by 55
Toll‐Like Receptor Expression and Response to Specific Stimulation in Adipocytes and Preadipocytes
Pietsch, J., Batra, A., STROH, T., Fedke, I., Glauben, R., Okur, B., Zeitz, M., & Siegmund, B. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1326.021 · Cited by 54
Givon, T., Slavin, S., Haran‐Ghera, N., Michalevicz, R., & Revel, M. (1992) · Blood · doi:10.1182/blood.v79.9.2392.2392 · Cited by 50
Cross-talk among gp130 Cytokines in Adipocytes
Zvonic, S., Baugh, J. E., Arbour-Reily, P., Mynatt, R. L., & Stephens, J. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508020200 · Cited by 49
Effects of estrogen versus estrogen and progesterone on cortisol and interleukin-6
Edwards, K. M., & Mills, P. J. (2008) · Maturitas · doi:10.1016/j.maturitas.2008.09.024 · Cited by 49
Fat Stress and Liver Resistance
Ogawa, W., & Kasuga, M. (2008) · Science · doi:10.1126/science.1167571 · Cited by 40
Components of Metabolic Syndrome Predicting Diabetes: No Role of Inflammation or Dyslipidemia
Norberg, M., Stenlund, H. C., Lindahl, B., Andersson, C., Weinehall, L., Hallmans, G., & Eriksson, J. W. (2007) · Obesity · doi:10.1038/oby.2007.222 · Cited by 34
Guðmundsson, A., Ershler, W. B., Goodman, B., Lent, S. J., Barczi, S. R., & Carnes, M. L. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.11.2199 · Cited by 33
Role of cytokines in cancer cachexia in a murine model of intracerebral injection of human tumours.
Negri, D. R. M., Mezzanzanica, D., Sacco, S., Gadina, M., Benigni, F., Cajola, L., Finocchiaro, G., Ghezzi, P., & Canevari, S. (2001) · Cytokine · doi:10.1006/cyto.2001.0899 · Cited by 28
Cited by
Makki, K., Froguel, P., & Wolowczuk, I. (2013) · ISRN Inflammation · doi:10.1155/2013/139239 · Cited by 1,085
Periodontitis is an inflammatory disease of oxidative stress: We should treat it that way
Sczepanik, F. S. C., Grossi, M. L., Casati, M., Goldberg, M., Glogauer, M., Fine, N., & Tenenbaum, H. C. (2020) · Periodontology 2000 · doi:10.1111/prd.12342 · Cited by 679
Changes in Nutritional Status Impact Immune Cell Metabolism and Function
Alwarawrah, Y., Kiernan, K., & MacIver, N. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01055 · Cited by 513
Preshaw, P. M., & Taylor, J. J. (2011) · Journal of Clinical Periodontology · doi:10.1111/j.1600-051x.2010.01671.x · Cited by 422
Metabolic regulation of the immune system in health and diseases: mechanisms and interventions
Hu, T., Liu, C.-H., Lei, M., Zeng, Q., Li, L., Tang, H., & Zhang, N. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01954-6 · Cited by 383
Metadata
- Authors
- Eder, K., Baffy, N., Falus, A., & Fulop, A. K.
- Venue
- Inflammation Research
- Published
- 2009-06-19
- Volume
- 58
- Issue
- 11
- Pages
- 727-736
- ISSN
- 1023-3830 (ISSN-L)
- 1420-908X
- OpenAlex
- W2054233490
- Cited by
- 433
- References
- 106
- FWCI
- 13.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.